Literature DB >> 21412500

Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.

Takumi Akiyama1, Toshihiko Mizuta, Seiji Kawazoe, Yuichiro Eguchi, Yasunori Kawaguchi, Hirokazu Takahashi, Iwata Ozaki, Kazuma Fujimoto.   

Abstract

AIM: To identify factors associated with the age at onset of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
METHODS: Five hundred and fifty-six consecutive patients positive for HCV antibody and treatment-naïve HCC diagnosed between 1995 and 2004 were analyzed. Patients were classified into three groups according to age at HCC onset: < 60 years (n = 79), 60-79 years (n = 439), or ≥ 80 years (n = 38). Differences among groups in terms of sex, body mass index (BMI), lifestyle characteristics, and liver function were assessed. Factors associated with HCC onset in patients < 60 or ≥ 80 years were analyzed by logistic regression analysis.
RESULTS: Significant differences emerged for sex, BMI, degree of smoking and alcohol consumption, mean bilirubin, alanine aminotransferase (ALT), and γ-glutamyl transpeptidase (GGT) levels, prothrombin activity, and platelet counts. The mean BMI values of male patients > 60 years old were lower and mean BMI values of female patients < 60 years old were higher than those of the general Japanese population. BMI > 25 kg/m² [hazard ratio (HR), 1.8, P = 0.045], excessive alcohol consumption (HR, 2.5, P = 0.024), male sex (HR, 3.6, P = 0.002), and GGT levels > 50 IU/L (HR, 2.4, P = 0.014) were independently associated with HCC onset in patients < 60 years. Low ALT level was the only factor associated with HCC onset in patients aged ≥ 80 years.
CONCLUSION: Increased BMI is associated with increased risk for early HCC development in HCV-infected patients. Achieving recommended BMI and reducing alcohol intake could help prevent hepatic carcinogenesis.

Entities:  

Keywords:  Age-at-onset; Alcohol consumption; Body mass index; Hepatitis C virus; Hepatocellular carcinoma; Sex difference

Mesh:

Year:  2011        PMID: 21412500      PMCID: PMC3051141          DOI: 10.3748/wjg.v17.i7.914

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese.

Authors:  Megumi Hara; Keitaro Tanaka; Tatsuhiko Sakamoto; Yasuki Higaki; Toshihiko Mizuta; Yuichiro Eguchi; Tsutomu Yasutake; Iwata Ozaki; Kyosuke Yamamoto; Shingo Onohara; Seiji Kawazoe; Hirohisa Shigematsu; Shunzo Koizumi
Journal:  Cancer Sci       Date:  2007-10-22       Impact factor: 6.716

2.  Hepatitis C virus, ER stress, and oxidative stress.

Authors:  Keith D Tardif; Gulam Waris; Aleem Siddiqui
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

Review 3.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 4.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.

Authors:  Hisayuki Hamada; Hiroshi Yatsuhashi; Koji Yano; Manabu Daikoku; Kokichi Arisawa; Osami Inoue; Michiaki Koga; Keisuke Nakata; Katsumi Eguchi; Michitami Yano
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

6.  Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

Authors:  Matteo Vidali; Marie-Francoise Tripodi; Alesandra Ivaldi; Rosa Zampino; Giuseppa Occhino; Luciano Restivo; Salvatore Sutti; Aldo Marrone; Giuseppe Ruggiero; Emanuele Albano; Luigi E Adinolfi
Journal:  J Hepatol       Date:  2007-12-03       Impact factor: 25.083

8.  Protection of estrogens against the progression of chronic liver disease.

Authors:  Ichiro Shimizu; Susumu Ito
Journal:  Hepatol Res       Date:  2007-04       Impact factor: 4.288

9.  Insulin resistance in experimental alcohol-induced liver disease.

Authors:  Suzanne M de la Monte; Jong-Eun Yeon; Ming Tong; Lisa Longato; Rajeev Chaudhry; Mao-Yin Pang; Kevin Duan; Jack R Wands
Journal:  J Gastroenterol Hepatol       Date:  2008-05-26       Impact factor: 4.029

10.  Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.

Authors:  H Tanaka; N Fujita; R Sugimoto; N Urawa; S Horiike; Y Kobayashi; M Iwasa; N Ma; S Kawanishi; S Watanabe; M Kaito; Y Takei
Journal:  Br J Cancer       Date:  2008-01-29       Impact factor: 7.640

View more
  7 in total

Review 1.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion.

Authors:  Yan-Feng Pan; Yan Zheng; Tao Qin; Lei Feng; Qian Zhang; Xiao-Gong Ping; Yan-Ting Pan; Xiao-Ping Wang; Li Bai; Hua-Hua Li
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

3.  Comparison of the clinical characteristics and survival between Uyghur patients with hepatitis virus-related and non-B, non-C hepatocellular carcinoma in Xinjiang, China.

Authors:  Lei Xiao; Rui-Li Zhang; Hua Zhang; Aisiker Tulahong; Yue-Fen Zhang; Hao Wen; Yong-Xing Bao
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

Review 4.  NAFLD, NASH and liver cancer.

Authors:  Gregory A Michelotti; Mariana V Machado; Anna Mae Diehl
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-01       Impact factor: 46.802

5.  The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.

Authors:  Hiroki Nishikawa; Akira Arimoto; Tomoko Wakasa; Ryuichi Kita; Toru Kimura; Yukio Osaki
Journal:  Gastroenterol Res Pract       Date:  2013-04-24       Impact factor: 2.260

6.  Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy.

Authors:  Xiyu Liu; Jiangfeng Xu
Journal:  Med Sci Monit       Date:  2015-07-29

7.  Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study.

Authors:  Ya-Ling Lee; Wan-Chun Li; Tung-Hu Tsai; Hsin-Yu Chiang; Chin-Tsung Ting
Journal:  Oncotarget       Date:  2016-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.